- Home
- THTX vs KRRO Comparison
THTX vs KRRO Comparison
Compare THTX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- KRRO
- Stock Information
- Founded
- THTX 1993
- KRRO 2014
- Country
- THTX Canada
- KRRO United States
- Employees
- THTX N/A
- KRRO N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- KRRO Health Care
- Exchange
- THTX Nasdaq
- KRRO Nasdaq
- Market Cap
- THTX 119.1M
- KRRO 101.4M
- IPO Year
- THTX N/A
- KRRO 2019
- Fundamental
- Price
- THTX $3.15
- KRRO $14.86
- Analyst Decision
- THTX Hold
- KRRO Strong Buy
- Analyst Count
- THTX 1
- KRRO 7
- Target Price
- THTX N/A
- KRRO $85.67
- AVG Volume (30 Days)
- THTX 1.0M
- KRRO 101.1K
- Earning Date
- THTX 07-09-2025
- KRRO 08-12-2025
- Dividend Yield
- THTX N/A
- KRRO N/A
- EPS Growth
- THTX N/A
- KRRO N/A
- EPS
- THTX N/A
- KRRO N/A
- Revenue
- THTX $84,378,000.00
- KRRO $4,821,000.00
- Revenue This Year
- THTX N/A
- KRRO $65.08
- Revenue Next Year
- THTX $15.13
- KRRO N/A
- P/E Ratio
- THTX N/A
- KRRO N/A
- Revenue Growth
- THTX 2.19
- KRRO N/A
- 52 Week Low
- THTX $1.12
- KRRO $10.29
- 52 Week High
- THTX $3.20
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- THTX 73.34
- KRRO 54.35
- Support Level
- THTX $2.28
- KRRO $12.27
- Resistance Level
- THTX $3.20
- KRRO $14.20
- Average True Range (ATR)
- THTX 0.09
- KRRO 1.01
- MACD
- THTX 0.09
- KRRO 0.23
- Stochastic Oscillator
- THTX 94.86
- KRRO 90.29
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.